Cargando…
Bioluminescence-Based High-Throughput Screen Identifies Pharmacological Agents That Target Neurotransmitter Signaling in Small Cell Lung Carcinoma
BACKGROUND: Frontline treatment of small cell lung carcinoma (SCLC) relies heavily on chemotherapeutic agents and radiation therapy. Though SCLC patients respond well to initial cycles of chemotherapy, they eventually develop resistance. Identification of novel therapies against SCLC is therefore im...
Autores principales: | Improgo, Ma. Reina D., Johnson, Christopher W., Tapper, Andrew R., Gardner, Paul D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169587/ https://www.ncbi.nlm.nih.gov/pubmed/21931655 http://dx.doi.org/10.1371/journal.pone.0024132 |
Ejemplares similares
-
Nicotinic acetylcholine receptors mediate lung cancer growth
por: Improgo, Ma. Reina, et al.
Publicado: (2013) -
High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides
por: Yang, B., et al.
Publicado: (2015) -
Pharmacological potentiators of the calcium signaling cascade identified by high-throughput screening
por: Genovese, Michele, et al.
Publicado: (2022) -
Screening of Fungi for Antimycobacterial Activity Using a Medium-Throughput Bioluminescence-Based Assay
por: Grey, Alexander B. J., et al.
Publicado: (2021) -
Diversity of small molecule HIV‐1 latency reversing agents identified in low‐ and high‐throughput small molecule screens
por: Hashemi, Pargol, et al.
Publicado: (2019)